Charles R. Goulding and Preeti Sulibhavi argue that Booz Allen’s Andreessen Horowitz investment proves 3D printing and AI are ...
Phase 1 Hawaiʻi is a sports performance facility that offers training programs for athletes of all ages, as well as the state’s first sports academy, a youth flag football league, and a ...
Hosted on MSN
Firestorm and Orqa partner to pioneer high-tech industrial manufacturing on front lines
SAN DIEGO, Feb. 10, 2026 /PRNewswire/ -- Today, Firestorm Labs. Inc, a defense tech company that solves contested logistics through expeditionary manufacturing, and Orqa, a world-leading developer and ...
The Firestorm Squall is U.S.-built with NDAA-compliant components, giving Orqa access to Firestorm's expertise and US based infrastructure. Together, the partnership will enable advanced unmanned ...
XCell Therapeutics (373110) has delivered a -65.09% change over the past year, with a 52-week range between 1,463.00 and 4,530.00. What Is the Average Daily Trading Volume of XCell Therapeutics ...
Taiwanese and US defense groups are collaborating to introduce deployable, semi-autonomous manufacturing systems for drones and components in a boost to the nation’s supply chain resilience. Taiwan’s ...
A Firestorm xCell micro 3D printing factory loading onto a C-130 to print Tempest UAV systems at a U.S. Air Force base. Inside a standard shipping container, a "factory-in-a-box" hums to life. It is ...
SAN FRANCISCO, CALIFORNIA, UNITED STATES, Dec. 09, 2025 (GLOBE NEWSWIRE) -- Xcell Biosciences Inc. (Xcellbio), an instrumentation company focused on cell and gene therapy applications, and Culture ...
Cloud-based platform combines AI and machine learning to perform multivariate analysis, enabling real-time optimization of cell therapy performance and patient outcomes SAN FRANCISCO, CALIFORNIA, ...
WASHINGTON: Malaysian Bio-XCell Sdn Bhd, launched last year as the commercial arm of government agency Malaysian Biotechnology Corp (BiotechCorp), expects to be profitable by 2014 or 2015. Bio-XCell ...
VORONOI said on the 27th that it presented phase 1 clinical data for VRN10 at the AACR-NCI-EORTC International Conference 2025, a global academic meeting co-hosted by the American Association for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results